Dynamic List Information
Dynamic List Data
Title
Bill Correctly for Inhalant Drugs
Date
2020-04-23
In a recent report, the Office of Inspector General (OIG) determined that CMS improperly paid suppliers for inhalation drugs. For billing, refer to the Medicare Provider Compliance Tips
- Medicare Benefit Policy Manual, Chapter 15 (PDF), Sections 110, 110.1, 110.3
- Medicare Program Integrity Manual, Chapter 5 (PDF), Sections 5.2, 5.7, 5.8, 5.9
- 2018 Medicare Fee-For-Service Supplemental Improper Payment Data (PDF) (data from Claims Submitted: July 1, 2016 – June 30, 2017)
- Medicare Improperly Paid Suppliers an Estimated $92.5 Million for Inhalation Drugs OIG Report, October 2019
- Liberty Medical, LLC, Received Unallowable Medicare Payments for Inhalation Drugs OIG Report, August 2018
- Lincare Pharmacy Services Inc. Generally Complied With Medicare Requirements When Billing for Inhalation Drugs OIG Report, December 2017